You can buy or sell AEZS and other stocks, options, ETFs, and crypto commission-free!
Aeterna Zentaris Inc. Common Stock, also called Aeterna Zentaris, is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. Read More It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.
Charleston, South Carolina
52 Week High
52 Week Low
Yahoo FinanceMar 19
Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019
CHARLESTON, S.C., March 19, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (AEZS) (AEZS) will announce its fourth quarter and year ended December 31, 2018 financial and operating results after market close on Tuesday, March 26, 2019. About Aeterna Zentaris Inc. Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is a party to a license and assignment agreement with a sub...
Yahoo FinanceMar 18
Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade
Aeterna Zentaris (AEZS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).
Markets InsiderMar 13
IIROC Trade Resumption - AEZS
TORONTO, March 13, 2019 /CNW/ - Trading resumes in: Company: AEterna Zentaris Inc. TSX Symbol: AEZS (all issues) Resumption (ET): 8:00 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada. SOURCE Investment Industry R...
-$0.19 per share
Available Mar 26, After Hours